What Happened?
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ: QDEL) jumped 14.9% in the afternoon session after the company's President and CEO, Brian Blaser, purchased 23,500 shares of company stock. The transaction, valued at approximately $501,490, was seen by investors as a strong vote of confidence in the company's future. Such a substantial purchase by a top executive often suggests a belief that the company is heading in the right direction or that its stock is undervalued. According to filings, the acquisition increased the CEO's holdings in the company by nearly 390%. This significant boost in ownership underscored his commitment and positive outlook, which resonated with the market.
The shares closed the day at $24.38, up 14.4% from previous close.
Is now the time to buy QuidelOrtho? Access our full analysis report here.
What Is The Market Telling Us
QuidelOrtho’s shares are extremely volatile and have had 35 moves greater than 5% over the last year. But moves this big are rare even for QuidelOrtho and indicate this news significantly impacted the market’s perception of the business.
The previous big move we wrote about was 10 days ago when the stock gained 10% on the news that the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns. This divergence was stark: the tech-heavy Nasdaq struggled, losing 0.2%, while the Dow rallied. This shift away from tech was triggered by a series of negative catalysts in the AI sector. AI cloud provider CoreWeave slid on disappointing guidance, while chip darling Nvidia pulled back after SoftBank sold its stake. This "hurt the AI trade," dragging down related names like Micron and Oracle. As capital left tech, it sought safety in "higher quality" defensive names. Health care giants like Merck, Amgen, and Johnson & Johnson saw significant buying, boosting the Dow.
QuidelOrtho is down 45.6% since the beginning of the year, and at $24.49 per share, it is trading 48.6% below its 52-week high of $47.61 from January 2025. Investors who bought $1,000 worth of QuidelOrtho’s shares 5 years ago would now be looking at an investment worth $139.06.
Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free for active Edge members and will only take you a second.
